Article | December 20, 2024 Due Diligence Decoded: Insights from In-House Counsel at Boston Program Read More
Article | December 19, 2024 Exploring the Loper Decision: Impacts on FDA-Regulated Transactions Read More
Article | December 17, 2024 Honesty is the Best Policy: Navigating the DOJ’s M&A Safe Harbor Read More
Article | December 15, 2024 Navigating the Complex Regulatory Landscape for AI/ML-Enabled Medical Devices Read More
Article | November 21, 2024 Post-Election FDA Landscape: Will There Be Regulatory Shifts Ahead in 2025 and Beyond? Read More